NCT01098058

Brief Summary

The purpose of the study is to compare the effectiveness of cognitive-behavioural therapy (CBT) plus treatment as usual with treatment as usual only in treating adults with attention deficit hyperactivity disorder (ADHD).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 19, 2010

Completed
13 days until next milestone

Study Start

First participant enrolled

April 1, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 2, 2010

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
Last Updated

April 19, 2016

Status Verified

April 1, 2016

Enrollment Period

4.4 years

First QC Date

March 19, 2010

Last Update Submit

April 18, 2016

Conditions

Keywords

Adult attention deficit hyperactivity disordercognitive-behavioural therapyrandomised controlled trial

Outcome Measures

Primary Outcomes (2)

  • Adult Barkley Current Behaviour Scale (Barkley 2006)

    18-item self-report measure assessing ADHD symptoms, rated on a 4-point Likert scale

    week 42

  • Work and Social Adjustment Scale (Mundt et al 2002)

    A reliable and valid self-report measure of impaired functioning attributable to an identified problem. It consists of 5 items, each rated on an 8-point scale

    week 42

Secondary Outcomes (10)

  • Clinical Global Impression Scales (Guy 1976)

    week 42

  • Clinical Outcomes in Routine Evaluation (CORE-OM) (Evans et al 2002)

    week 42

  • Hospital anxiety and depression scale (Zigmond and Snaith 1983)

    week 42

  • ADHD Beliefs Questionnaire

    week 42

  • ADHD Behaviours Questionnaire

    week 42

  • +5 more secondary outcomes

Study Arms (2)

CBT plus treatment as usual

EXPERIMENTAL
Other: CBT plus treatment as usual

Treatment as usual

ACTIVE COMPARATOR

Treatment as usual appointments at the Adult ADHD Service - typically one 30-minute appointment every three to six months

Other: Treatment as usual

Interventions

16 one-hour therapy sessions taking place over 42 weeks in addition to usual medical follow-up appointments

CBT plus treatment as usual

Treatment as usual appointments at the Adult ADHD Service - typically one 30-minute appointment every three to six months

Treatment as usual

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A diagnosis of adult ADHD according to NICE guidelines i.e. if there was evidence from both the participant and the informant (where available) that 1) the participant met DSM-IV criteria for Adult ADHD both in childhood and adulthood 2) that they experienced at least moderate psychological, social and/or educational or occupational impairment in multiple settings and 3) symptoms occurred in two or more settings including social, familial, educational and/or occupational settings. Participants will have received a diagnosis either from the Adult ADHD Service, Maudsley Hospital, London, UK or another specialist/secondary care service (in this case a copy of the diagnostic report will be required). Participants will either already be attending follow-up clinics, including psychoeducation workshops, or will have been recently referred to the service for medication follow-up or psychological treatment.
  • Currently score 6 or more on the inattentive or hyperactive/impulsive subscale of the Adult Barkley Current Behaviour Scale
  • Clinical severity of at least a moderate level (Clinical Global Impression score of 4 or above)
  • Able to attend the clinic regularly and reliably

You may not qualify if:

  • Clinically significant anxiety disorder
  • Current episode major depression, current suicidality or self-harm (score of moderate or high suicidality on the M.I.N.I.)
  • Acquired brain injury
  • Primary diagnosis of psychosis or bipolar disorder
  • Pervasive developmental disorder(score of \<= 32 on Autism Spectrum Quotient - although if the assessor judges that items that confound with ADHD have caused the score to be elevated, people with scores \>=32 can still enter the trial)
  • Diagnosis of personality disorder
  • Active substance misuse/dependence in last three months
  • Verbal IQ \<80
  • Not able to comply with the requirements of a randomised controlled trial
  • If the assessor does not perceive ADHD to be the primary problem

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Adult ADHD Service, South London and Maudsley NHS Foundation Trust

London, London, Se5 8AZ, United Kingdom

Location

Related Publications (7)

  • Barkley R.A. (2006) Attention-Deficit Hyperactivity Disorder - A Handbook for Diagnosis and Treatment. Third Edition, The Guildford Press, New York.

    BACKGROUND
  • Rosenberg, M. (1965). Society and The Adolescent Self-Image. Princeton, N.J.: Princeton University Press.

    BACKGROUND
  • Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). American Psychiatric Association, 2000.

    BACKGROUND
  • Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x.

    PMID: 6880820BACKGROUND
  • Evans C, Connell J, Barkham M, Margison F, McGrath G, Mellor-Clark J, Audin K. Towards a standardised brief outcome measure: psychometric properties and utility of the CORE-OM. Br J Psychiatry. 2002 Jan;180:51-60. doi: 10.1192/bjp.180.1.51.

    PMID: 11772852BACKGROUND
  • Guy W (ed). ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: US Department of Heath, Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration, 1976.

    BACKGROUND
  • Mundt JC, Marks IM, Shear MK, Greist JH. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry. 2002 May;180:461-4. doi: 10.1192/bjp.180.5.461.

    PMID: 11983645BACKGROUND

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Study Officials

  • Antonia J Dittner, D Clin Psy

    South London and Maudsley NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Clinical Psychologist

Study Record Dates

First Submitted

March 19, 2010

First Posted

April 2, 2010

Study Start

April 1, 2010

Primary Completion

September 1, 2014

Study Completion

September 1, 2014

Last Updated

April 19, 2016

Record last verified: 2016-04

Locations